Innovations in Oncology

Program Overview

The 3rd International Symposium "Innovations In Oncology" will open for registration on 26 June 2017 at 08:45 AM. On 27 June 2017 registration will be open from 08:30 AM.

Satellite Symposium (with friendly support of Roche AG)

June 26, 2017: 09:15 PM – 6:20 PM

Morning Coffee/Registration

09:15-09:25 Welcome
Stefan Frings, Roche Pharma AG /
Christof von Kalle, National Center for Tumor Diseases (NCT) Heidelberg

09:25-09:40   
Tapping into External Innovation (TBC)
Gad Bitton, Roche Pharma Finance Group Mergers & Acquisitions

09:45-10:00   
Data in the Real World Applied to Drug Development to Boost Innovation
Adrian Cassidy , Roche RWD-S Oncology

10:05-10:20   
Integrating Big Data and NGS into Drug Development to Advance PHC
Astrid Kiermaier, Oncology Biomarker Development, Roche/Genentech

10:25-11:00 Panel Discussion



Symposium "Innovations in Oncology"

June 26, 2017: 09:15 PM – 6:20 PM

Welcome Lunch


Christa Maar, Christof von Kalle


Chairs: Rita Schmutzler (conf.), Evelin Schröck (TBC)

12:30-12:45   
How Do We Interpret Familiality in Colorectal Cancer?
C. Richard Boland, University of California, San Diego

12:50-13:05   
Defining the Unknown Unknowns of Colon Cancer
Richard Houlston, The Institute of Cancer Research, London

13:10-13:25   
Metagenomics and the Host-Microbe Interface
Ami Bhatt, Stanford Unversity

13:30-13:45   
A First World Problem: how Lifestyle Factors Influence the Risk of Developing CRC
Martha Shrubsole, Vanderbilt University Medical Center, Nashville

Coffee Break and Visual Applause


Johannes Bruns (conf.), Thomas Schnelle / Metaplan (conf.)

14:10-14:25  
Pre-mortem
Johannes Bruns, German Cancer Society, Berlin       

14:25-15:50   
Panel Discussion
Moderated by Thomas Schnelle, Metaplan, Hamburg       

Coffee Break and Visual Applause

The German Cancer Consortium (DKTK): An Innovative Platform for Bench-to-Bedside Research
Otmar D. Wiestler, Helmholtz Association, Berlin



Chairs: Hermann Brenner (conf.), Frank Kolligs (conf.)

17:00-17:15  
Blood, Sweat, No Tears: the Liquid Biopsy of Colon Cancer
Thomas Seufferlein, University Clinics Ulm

17:20-17:35   
To See or Not to See: Advances in Imaging Techniques
Maximilian Reiser, Ludwigs-Maximilians-University Munich

17:40-17:55   
Hot Air or Hot Trail? Diagnosis of Diseases from Breath Tests
Hossam Haick, Technion - Israel Institute of Technology, Israel

18:00-18:15   
Potential of Human Fecal Microbiota for Early Stage Detection of Colorectal Cancer  
Peer Bork, European Molecular Biology Laboratory, Heidelberg
                   


Evening Reception

June 27, 2017: 9:00 AM – 6:10 PM

Morning Coffee

What’s App, Doc? The Power of Comprehensive Health Records
Andrew Morris, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh


Chairs: Arno Elmer (conf.), Michael Hallek (conf.)

09:40-09:55
CancerLinQ: Utilizing Real World Evidence to Improve Patient Outcomes
George Komatsoulis, ASCO CancerLinQ

10:00-10:15   
Turning Data Sharing into Practice
Gerrit A. Meijer, AACR GeniE / Netherlands Cancer Institute, Amsterdam

10:20-10:35   
Genetic Testing: Data Sharing and Data Complexity
Rolf Sijmons, University of Groningen                    

10:40-10:55   
ColonFlag - The Implementation of a Machine Learning Algorithm to Flag Individuals Harbouring Pre-Cancerous and Cancerous Colonic Lesions within a Large Health Maintenance Organisation
Ran Goshen, Medial EarlySign, Israel

Coffee Break and Visual Applause

Moderated by Thomas Schnelle / Metaplan

Lunch Break


Chair: Justus Duyster (conf.), Jürgen Riemann (conf.)

14:00-14:30   
News in Colorectal Cancer from ASCO 2017
Diana Lüftner, Charité University Clinics, Berlin


Chairs: Georg Ralle (conf.), J. Rüdiger Siewert (conf.)


14:30-14.40    Bristol-Myers Squibb GmbH & Co.KGaA, München
14:45-14:55    Merck Serono GmbH, Darmstadt
15:00-15:10    MSD SHARP & DOHME GMBH, Haar b. München
15:15-15:25    Norgine GmbH, Marburg
15:30-15:40    Olympus Deutschland GmbH, Hamburg
15:45-15:55    Pfizer Pharma GmbH, Berlin
16:00-16:10    Roche Pharma AG, Grenzach-Wyhlen

Coffee Break and Visual Applause


Chairs: Dirk Jäger (conf.), Johannes Bruns (conf.)


16:30-16:45   
T-Cell Transfer Immunotherapy Targeting the Gastrointestinal Cancer Mutanome
Eric Tran, Earle A. Chiles Research Institute, Providence Cancer Center, Portland

16:50-17:05       
Harnessing the Innate Immune System: Macrophage Repolarization via CCR5 Inhibition
Niels Halama, National Center for Tumor Diseases (NCT) Heidelberg/University Hospital, Heidelberg

17:10-17:25   
CEA-Targeted T-Cell Bispecific Antibody and Next Generation Immunomodulators for the Treatment of Colon Cancer and Other Solid Tumors
Pablo Umaña, Roche Innovation Center, Zürich

Christof von Kalle (conf.)

Get Together